Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
AGIOS PHARMACEUTICALS, INC. has filed 1,294 SEC EDGAR filings since 01 Jul 2008

SEC filing history

Showing 851-875 of 1,000 matching filings.

Per page
25
Current page
35
4

FORM 4 SUBMISSION

Filing date
15 Jun 2017
Reporting date
13 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2017
Reporting date
13 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36014

FORM 8-K

Filing date
14 Jun 2017
Reporting date
13 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jun 2017
Reporting date
06 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36014

FORM 8-K

Filing date
06 Jun 2017
Reporting date
03 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 May 2017
Reporting date
27 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
31 May 2017
Reporting date
27 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36014

FORM 8-K

Filing date
31 May 2017
Reporting date
27 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 May 2017
Reporting date
24 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87570

SC 13G/A filing

Filing date
09 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36014

FORM 8-K

Filing date
05 May 2017
Reporting date
01 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36014

FORM 8-K

Filing date
04 May 2017
Reporting date
04 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 May 2017
Reporting date
01 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87570

AMENDMENT NO. 3 TO SCHEDULE 13D

Filing date
24 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Apr 2017
Reporting date
24 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36014

DEFA14A

Filing date
24 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36014

DEF 14A

Filing date
24 Apr 2017
Reporting date
13 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Apr 2017
Reporting date
17 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36014

8-K

Filing date
19 Apr 2017
Reporting date
18 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-200822

424B5

Filing date
19 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-200822

424B5

Filing date
17 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Apr 2017
Reporting date
03 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Apr 2017
Reporting date
03 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Mar 2017
Reporting date
22 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .